McKesson (MCK) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

North American Pharmaceutical SegmentOncology And Multispecialty SegmentMedical-Surgical Solutions SegmentPrescription Technology Solutions SegmentSegment Reporting, Reconciling Item, Excluding Corporate NonsegmentU.S. Pharmaceutical SegmentInternational SegmentPrescription Technology Solutions
038B75B112B150B188B225B262B300BQ4 2025Q1 2026Q2 2026Q3 2026Q4 2026

Revenue by Geography

International Segment
0625M1B2B2B3B4B4B5BQ4 2025Q1 2026Q2 2026Q3 2026Q4 2026

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
025B50B75B100B125B150B175B200BQ4 2025Q1 2026Q2 2026Q3 2026Q4 2026

Margin (%)

Gross MarginOperating MarginNet Income Margin
0124568910Q4 2025Q1 2026Q2 2026Q3 2026Q4 2026

Operating Expenses

Selling And Marketing ExpensesOther Expenses
0625M1B2B2B3B4B4B5BQ4 2025Q1 2026Q2 2026Q3 2026Q4 2026

EBITDA

EBITDA
0375M750M1B2B2B2B3B3BQ4 2025Q1 2026Q2 2026Q3 2026Q4 2026

EPS

EPSEPS Diluted
0510152025303540Q4 2025Q1 2026Q2 2026Q3 2026Q4 2026

Revenue Variation (%)

Revenue Variation
-20-16-13-9-6-2259Q4 2025Q1 2026Q2 2026Q3 2026Q4 2026

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
0255075100125150175200Q4 2025Q1 2026Q2 2026Q3 2026Q4 2026

Revenue YoY Variation (%)

Revenue YoY Variation
048111519222630Q4 2025Q1 2026Q2 2026Q3 2026Q4 2026

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
075150225300375450525600Q4 2025Q1 2026Q2 2026Q3 2026Q4 2026

Price-to-Earning Ratio

P/E Ratio
0510152025303540Q4 2025Q1 2026Q2 2026Q3 2026Q4 2026

Income Breakdown

Rule Of 40 (EBITDA)Rule Of 40 (FCF)
0815223038455260Q4 2025Q1 2026Q2 2026Q3 2026Q4 2026

Per Share Metrics

Operating IncomeTotal Other Income Expenses NetNet Income
0625M1B2B2B3B4B4B5BQ4 2025Q1 2026Q2 2026Q3 2026Q4 2026

Expense Ratios

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
02505007501K1K2K2K2KQ4 2025Q1 2026Q2 2026Q3 2026Q4 2026
💰 Cash Flow Statement

Operating Cash Flow

Capex To Revenue
000001111Q4 2025Q1 2026Q2 2026Q3 2026Q4 2026

Free Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
02B5B8B10B12B15B18B20BQ4 2025Q1 2026Q2 2026Q3 2026Q4 2026

Cash Flow to Debt Ratio

Cash At End Of Period
0875M2B3B4B4B5B6B7BQ4 2025Q1 2026Q2 2026Q3 2026Q4 2026
🏦 Balance Sheet
📈 Key Metrics